SRC and breast cancer: Pyk2 is a critical component of Ca2+-induced signaling pathways controlling cell survival in lung cancer (66), Src activation and metastasis in breast cancer (41), and in neuroprotection through the Pyk2/ERK/CREB pathway (84).